Home > Income Statement > MANKIND PHARMA

MANKIND PHARMA
Consolidated Net Profit

    Back to Income Statement
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹1,913 Cr₹128,186 Cr₹1,433 Cr₹127 Cr₹10,304 Cr

What is the latest Consolidated Net Profit of MANKIND PHARMA ?

The latest Consolidated Net Profit ratio of MANKIND PHARMA is ₹1,913 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹1,913 Cr
Mar2024₹128,186 Cr
Mar2023₹1,433 Cr
Mar2022₹127 Cr
Mar2021₹10,304 Cr

How is Consolidated Net Profit of MANKIND PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹1,913 Cr
-98.51
Mar2024 ₹128,186 Cr
8,842.31
Mar2023 ₹1,433 Cr
1,032.80
Mar2022 ₹127 Cr
-98.77
Mar2021 ₹10,304 Cr -

Compare Consolidated Net Profit of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹98,271.3 Cr 0.9% -1.2% 0.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,620.0 Cr 1% -0.9% 6.8% Stock Analytics
DIVIS LABORATORIES ₹176,087.0 Cr 1.8% -2.3% 1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹154,837.0 Cr 3.7% 6.5% 44.9% Stock Analytics
CIPLA ₹112,194.0 Cr 0% 4.7% -8% Stock Analytics
DR REDDYS LABORATORIES ₹106,328.0 Cr -0.2% 0.7% -3.4% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

0.9%

-1.2%

0.8%

SENSEX

1.7%

1.3%

-7.3%


You may also like the below Video Courses